(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Gevo, Inovio Pharmaceuticals, and Infosys Limited.

The three biggest losers today are Xenetic Biosciences, Bionano Genomics, and HSBC.

Premarket Winners today

1. Gevo (GEVO) – Premarket: 3.14%

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo jumping 1.92% to $1.59 on Friday, following the last session’s upward trend. NASDAQ slid 0.1% to $13,959.71, after three sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.72%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 16.7% and 73.7%, respectively.

More news about Gevo.

2. Inovio Pharmaceuticals (INO) – Premarket: 1.31%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals sliding 1.03% to $0.47 on Friday, after three sequential sessions in a row of losses. NASDAQ slid 0.1% to $13,959.71, after three sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Inovio Pharmaceuticals’s EBITDA is 0.14.

Revenue Growth

Year-on-year quarterly revenue growth declined by 42.3%, now sitting on 10.18M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 69.6% and 13.3%, respectively.

More news about Inovio Pharmaceuticals.

3. Infosys Limited (INFY) – Premarket: 1.15%

Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application management and application development services, independent validation solutions, product engineering and management, infrastructure management services, traditional enterprise application implementation, support, and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Panaya platform, Infosys Equinox, Infosys Helix, Infosys Applied AI, Infosys Cortex, and Stater digital platforms; and Infosys McCamish, an insurance platform. It serves enterprises in the financial services and insurance, manufacturing, retail, consumer packaged goods, logistics, energy, utilities, resources, services, communications, telecom OEM, media, hi-tech, and life sciences and healthcare industries. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.

NYSE ended the session with Infosys Limited dropping 0.06% to $16.51 on Friday while NYSE dropped 0.3% to $16,125.42.

Earnings Per Share

As for profitability, Infosys Limited has a trailing twelve months EPS of $0.69.

PE Ratio

Infosys Limited has a trailing twelve months price to earnings ratio of 23.93. Meaning, the purchaser of the share is investing $23.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.04%.

Yearly Top and Bottom Value

Infosys Limited’s stock is valued at $16.51 at 08:34 EST, way under its 52-week high of $20.60 and way higher than its 52-week low of $14.71.

More news about Infosys Limited.

4. Vanguard Total International Bond (BNDX) – Premarket: 1.13%

NASDAQ ended the session with Vanguard Total International Bond falling 0.27% to $48.35 on Friday while NASDAQ dropped 0.1% to $13,959.71.

Earnings Per Share

As for profitability, Vanguard Total International Bond has a trailing twelve months EPS of $1.75.

More news about Vanguard Total International Bond.

5. iShares (PFF) – Premarket: 1.04%

NASDAQ ended the session with iShares dropping 0.85% to $30.48 on Friday, after three consecutive sessions in a row of losses. NASDAQ dropped 0.1% to $13,959.71, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, iShares has a trailing twelve months EPS of $6.75.

PE Ratio

iShares has a trailing twelve months price to earnings ratio of 3.78. Meaning, the purchaser of the share is investing $3.78 for every dollar of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, iShares’s stock is considered to be overbought (>=80).

Volatility

iShares’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a negative 0.09%, and a positive 0.48%.

iShares’s highest amplitude of average volatility was 0.76% (last week), 0.55% (last month), and 0.48% (last quarter).

More news about iShares.

6. FuelCell Energy (FCEL) – Premarket: 0.98%

FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.

NASDAQ ended the session with FuelCell Energy rising 1% to $2.03 on Friday, following the last session’s upward trend. NASDAQ slid 0.1% to $13,959.71, after three sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.31.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.18%.

More news about FuelCell Energy.

7. Ecopetrol S.A. (EC) – Premarket: 0.88%

Ecopetrol S.A. operates as an integrated energy company. The company operates through four segments: Exploration and Production; Transport and Logistics; Refining, Petrochemical and Biofuels; and Electric Power Transmission and Toll Roads Concessions. It engages in the exploration and production of oil and gas; transportation of crude oil, motor fuels, fuel oil, and other refined products, including diesel, jet, and biofuels; processing and refining crude oil; distribution of natural gas and LPG; sale of refined and petrochemical products; supplying of electric power transmission services; design, development, construction, operation, and maintenance of road and energy infrastructure projects; and supplying of information technology and telecommunications services. As of December 31, 2022, the company had approximately 9,127 kilometers of crude oil and multi-purpose pipelines. It also produces and commercializes polypropylene resins and compounds, and masterbatches; and offers industrial service sales to customers and specialized management services. It has operations in Colombia, the United States, Asia, Central America and the Caribbean, Europe, and South America. The company was formerly known as Empresa Colombiana de Petróleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was incorporated in 1948 and is headquartered in Bogotá, Colombia.

NYSE ended the session with Ecopetrol S.A. rising 0.63% to $11.25 on Friday, after two successive sessions in a row of gains. NYSE slid 0.3% to $16,125.42, after three successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Ecopetrol S.A. has a trailing twelve months EPS of $3.82.

PE Ratio

Ecopetrol S.A. has a trailing twelve months price to earnings ratio of 2.95. Meaning, the purchaser of the share is investing $2.95 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.9%.

Yearly Top and Bottom Value

Ecopetrol S.A.’s stock is valued at $11.25 at 08:34 EST, below its 52-week high of $12.35 and way above its 52-week low of $8.59.

Sales Growth

Ecopetrol S.A.’s sales growth is negative 22.3% for the ongoing quarter and negative 22.1% for the next.

Volatility

Ecopetrol S.A.’s last week, last month’s, and last quarter’s current intraday variation average was 0.18%, 0.37%, and 1.51%.

Ecopetrol S.A.’s highest amplitude of average volatility was 2.58% (last week), 1.52% (last month), and 1.51% (last quarter).

More news about Ecopetrol S.A..

8. Canaan (CAN) – Premarket: 0.71%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan dropping 3.61% to $2.81 on Friday, after three sequential sessions in a row of losses. NASDAQ dropped 0.1% to $13,959.71, after three sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.4%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be overbought (>=80).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canaan’s EBITDA is -2.02.

Yearly Top and Bottom Value

Canaan’s stock is valued at $2.81 at 08:34 EST, way under its 52-week high of $4.38 and way higher than its 52-week low of $1.83.

More news about Canaan.

9. iShares Short-Term (IGSB) – Premarket: 0.28%

NASDAQ ended the session with iShares Short-Term falling 0.04% to $50.04 on Friday while NASDAQ fell 0.1% to $13,959.71.

Earnings Per Share

As for profitability, iShares Short-Term has a trailing twelve months EPS of $2.61.

More news about iShares Short-Term.

10. Upwork (UPWK) – Premarket: 0%

Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including sales and marketing, customer service, data science and analytics, design and creative, web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Enterprise, and Upwork Payroll, as well as managed and internet escrow agency services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

NASDAQ ended the session with Upwork jumping 44.18% to $14.38 on Friday while NASDAQ dropped 0.1% to $13,959.71.

Earnings Per Share

As for profitability, Upwork has a trailing twelve months EPS of $-0.65.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.83%.

Previous days news about Upwork

• : upwork stock jumps nearly 20% after freelance platform swings to adjusted Q2 profit, revenue rises 7%. According to MarketWatch on Wednesday, 2 August, "Shares of Upwork Inc. rallied nearly 20% in the aftermarket Wednesday after the platform for freelancers narrowed its quarterly loss, swinging to an adjusted profit, and reported revenue above Wall Street expectations. ", "Our continued focus as a management team is on innovation, cost discipline, and identifying the highest [return-on-investment] to generate profitable growth and shareholder value." Shares of Upwork ended the regular trading day down 0.5%."
• Upwork (upwk) Q2 earnings and revenues beat estimates. According to Zacks on Wednesday, 2 August, "While Upwork has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
• Upwork (upwk) reports Q2 earnings: what key metrics have to say. According to Zacks on Wednesday, 2 August, "For the quarter ended June 2023, Upwork (UPWK Quick QuoteUPWK – Free Report) reported revenue of $168.61 million, up 7.5% over the same period last year. ", "Here is how Upwork performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"

More news about Upwork.

Premarket Losers Today

1. Xenetic Biosciences (XBIO) – Premarket: -3.38%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences rising 1.32% to $3.84 on Friday, following the last session’s downward trend. NASDAQ slid 0.1% to $13,959.71, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-4.37.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.06%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Xenetic Biosciences’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $3.84 at 08:34 EST, way below its 52-week high of $9.94 and way higher than its 52-week low of $2.40.

Moving Average

Xenetic Biosciences’s worth is way higher than its 50-day moving average of $3.40 and under its 200-day moving average of $4.24.

More news about Xenetic Biosciences.

2. Bionano Genomics (BNGO) – Premarket: -1.27%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics jumping 2.89% to $0.59 on Friday while NASDAQ fell 0.1% to $13,959.71.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-0.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.51%.

More news about Bionano Genomics.

3. HSBC (HSBC) – Premarket: -1.12%

HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions. This segment serves personal banking and high net worth individuals. The Commercial Banking segment provides credit and lending, treasury management, payment, cash management, commercial insurance, and investment services; commercial cards; international trade and receivables finance services; foreign exchange products; capital raising services on debt and equity markets; and advisory services. It serves small and medium sized enterprises, mid-market enterprises, and corporates. The Global Banking and Markets segment offers financing, advisory, and transaction services; and credit, rates, foreign exchange, equities, money markets, and securities services; and engages in principal investment activities. It serves government, corporate and institutional clients, and private investors. HSBC Holdings plc was founded in 1865 and is headquartered in London, the United Kingdom.

NYSE ended the session with HSBC jumping 0.82% to $40.99 on Friday while NYSE slid 0.3% to $16,125.42.

Earnings Per Share

As for profitability, HSBC has a trailing twelve months EPS of $5.6.

PE Ratio

HSBC has a trailing twelve months price to earnings ratio of 7.32. Meaning, the purchaser of the share is investing $7.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.07%.

Yearly Top and Bottom Value

HSBC’s stock is valued at $40.99 at 08:34 EST, below its 52-week high of $42.05 and way higher than its 52-week low of $24.77.

Volume

Today’s last reported volume for HSBC is 1293150 which is 13.54% below its average volume of 1495690.

Volatility

HSBC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.89%, a positive 0.12%, and a positive 0.98%.

HSBC’s highest amplitude of average volatility was 1.65% (last week), 1.04% (last month), and 0.98% (last quarter).

Previous days news about HSBC

• HSBC CEO on farage-coutts spat: 'we do not exit clients based on their lawful personal views'. According to CNBC on Wednesday, 2 August, "LONDON – HSBC CEO Noel Quinn said Tuesday that the lender would not "exit a client based on their lawful personal views," after Coutts’ termination of Brexit figurehead Nigel Farage’s account sparked a banking scandal in the U.K.", "Although refusing to discuss details of other banks and their clients, HSBC boss Quinn told CNBC on Tuesday that "our policy is not to de-bank or exit a client based on their lawful personal views."

More news about HSBC.

4. Texas Instruments (TXN) – Premarket: -0.76%

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. It operates in two segments, Analog and Embedded Processing. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products. This segment also provides signal chain products that sense, condition, and measure signals to allow information to be transferred or converted for further processing and control, including amplifiers, data converters, interface products, motor drives, clocks, and logic and sensing products. The Embedded Processing segment offers microcontrollers that are used in electronic equipment; digital signal processors for mathematical computations; and applications processors for specific computing activity. This segment offers products for use in various markets, such as industrial, automotive, personal electronics, communications equipment, enterprise systems, and calculators and other. The company also provides DLP products primarily for use in project high-definition images; calculators; and application-specific integrated circuits. It markets and sells its semiconductor products through direct sales and distributors, as well as through its website. Texas Instruments Incorporated was founded in 1930 and is headquartered in Dallas, Texas.

NASDAQ ended the session with Texas Instruments sliding 0.37% to $171.80 on Friday, after three consecutive sessions in a row of losses. NASDAQ dropped 0.1% to $13,959.71, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Texas Instruments has a trailing twelve months EPS of $8.91.

PE Ratio

Texas Instruments has a trailing twelve months price to earnings ratio of 19.28. Meaning, the purchaser of the share is investing $19.28 for every dollar of annual earnings.

More news about Texas Instruments.

5. Vodafone (VOD) – Premarket: -0.22%

Vodafone Group Public Limited Company provides telecommunication services in Europe and internationally. It offers mobile connectivity services comprising end-to-end services for mobile voice and data, messaging, device management, BYOx, and telecoms management, as well as professional and consulting services; and fixed line connectivity, such as fixed voice and data, broadband, software-defined networks, managed WAN, LAN, ethernet, and satellite; and financial services, as well as business and merchant services. The company also provides consumer Internet of Things (IoT) propositions, as well as security and insurance products; mobile services; logistics, fleet management, and smart metering services; WiFi; digital services comprising mobile application development, multi-access edge computing, worker insights, AI assistant, drone detection, visual inspection, and mixed reality, as well as Vodafone Analytics platform; and traditional IT hosting services, including colocation, managed hosting, security, hosting infrastructure, and flexible computing for government. In addition, it offers integrated business communication services, as well as fixed mobile convergence services; and carrier services, as well as IoT devices comprising managed tablets and integrated terminals. Further, it offers M-Pesa, an African mobile money platform to make payments and provide financial services; Vodafone Business multi-cloud platform; and productivity solutions, as well as operates digital cloud-based television platforms. It serves private and public sector customers in the manufacturing, retail, automotive, banking finance, healthcare, smart cities and public, agriculture, transport and logistics, and energy and utilities management industries. It offers its products and services through digital and physical channels. Vodafone Group Public Limited Company has a strategic partnership with Open Fiber. The company was incorporated in 1984 and is based in Newbury, the United Kingdom.

NASDAQ ended the session with Vodafone sliding 1.86% to $9.26 on Friday, after four sequential sessions in a row of losses. NASDAQ fell 0.1% to $13,959.71, after three sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Vodafone has a trailing twelve months EPS of $4.72.

PE Ratio

Vodafone has a trailing twelve months price to earnings ratio of 1.96. Meaning, the purchaser of the share is investing $1.96 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.3%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 0.98 and the estimated forward annual dividend yield is 10.02%.

More news about Vodafone.

6. Smith & Wesson (SWBI) – Premarket: -0.16%

Smith & Wesson Brands, Inc. designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, and Gemtech brands. It also provides manufacturing services comprising forging, heat treating, rapid prototyping, tooling, finishing, plating, machining, and custom plastic injection molding to other businesses under the Smith & Wesson and Smith & Wesson Precision Components brand names; and sells parts purchased through third parties. The company sells its products to firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement, security agencies and officers, and military agencies. It markets its products through independent dealers, retailers, in-store retails, and direct to consumers; print, broadcast, and digital advertising campaigns; social and electronic media; and in-store retail merchandising strategies. Smith & Wesson Brands, Inc. was founded in 1852 and is based in Springfield, Massachusetts.

NASDAQ ended the session with Smith & Wesson rising 0.36% to $12.56 on Friday, following the last session’s upward trend. NASDAQ slid 0.1% to $13,959.71, after three consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Smith & Wesson has a trailing twelve months EPS of $0.81.

PE Ratio

Smith & Wesson has a trailing twelve months price to earnings ratio of 15.5. Meaning, the purchaser of the share is investing $15.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.9%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 20.1%, now sitting on 479.24M for the twelve trailing months.

Volatility

Smith & Wesson’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.50%, a negative 0.22%, and a positive 1.61%.

Smith & Wesson’s highest amplitude of average volatility was 0.70% (last week), 0.88% (last month), and 1.61% (last quarter).

More news about Smith & Wesson.

7. Five9 (FIVN) – Premarket: -0.04%

Five9, Inc., together with its subsidiaries, provides intelligent cloud software for contact centers in the United States and internationally. The company offers virtual contact center cloud platform that delivers a suite of applications, which enables the breadth of contact center-related customer service, sales, and marketing functions. Its platform allows to manage and optimize customer interactions across voice, chat, email, web, social media, and mobile channels directly or through its application programming interfaces. The company serves customers in various industries, such as banking and financial services, business process outsourcers, retail, healthcare, technology, and education. Five9, Inc. was incorporated in 2001 and is headquartered in San Ramon, California.

NASDAQ ended the session with Five9 falling 0.43% to $81.88 on Friday, after three successive sessions in a row of losses. NASDAQ fell 0.1% to $13,959.71, after three successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Five9 has a trailing twelve months EPS of $-1.22.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.72%.

Sales Growth

Five9’s sales growth is 13.1% for the present quarter and 16.8% for the next.

Yearly Top and Bottom Value

Five9’s stock is valued at $81.88 at 08:34 EST, way below its 52-week high of $120.39 and way higher than its 52-week low of $46.61.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 14.7% and 10.3%, respectively.

More news about Five9.

8. Merrimack Pharmaceuticals (MACK) – Premarket: 0%

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Merrimack Pharmaceuticals dropping 0% to $11.86 on Friday while NASDAQ slid 0.1% to $13,959.71.

Earnings Per Share

As for profitability, Merrimack Pharmaceuticals has a trailing twelve months EPS of $-0.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.12%.

More news about Merrimack Pharmaceuticals.

9. GoPro (GPRO) – Premarket: 0%

GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, HERO9 Black, and HERO8 Black waterproof cameras; MAX, a 360-degree waterproof camera; GoPro, a subscription service that includes full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik app, a mobile app that enable users to get their favorite photos and videos with footage from any phone or camera. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, magnetic swivel clips, chest harnesses, and head straps; media, display, and light mods; spare batteries, dive filters, and charging accessories and cables; and lifestyle gears. In addition, the company provides mobile and web applications that provides media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its GoPro.com website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2002 and is headquartered in San Mateo, California.

NASDAQ ended the session with GoPro jumping 2.36% to $4.12 on Friday, following the last session’s upward trend. NASDAQ fell 0.1% to $13,959.71, after three sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Gopro (gpro) Q2 earnings: taking a look at key metrics versus estimatesHere is how GoPro performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, GoPro has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.14%.

More news about GoPro.

10. Upwork (UPWK) – Premarket: 0%

Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including sales and marketing, customer service, data science and analytics, design and creative, web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Enterprise, and Upwork Payroll, as well as managed and internet escrow agency services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

NASDAQ ended the session with Upwork rising 44.18% to $14.38 on Friday, following the last session’s upward trend. NASDAQ slid 0.1% to $13,959.71, after three consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Upwork has a trailing twelve months EPS of $-0.65.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.83%.

Previous days news about Upwork

• : upwork stock jumps nearly 20% after freelance platform swings to adjusted Q2 profit, revenue rises 7%. According to MarketWatch on Wednesday, 2 August, "Shares of Upwork Inc. rallied nearly 20% in the aftermarket Wednesday after the platform for freelancers narrowed its quarterly loss, swinging to an adjusted profit, and reported revenue above Wall Street expectations. ", "Analysts polled by FactSet expected Upwork to break even on an adjusted basis and to report revenue of $163 million. "
• Upwork (upwk) Q2 earnings and revenues beat estimates. According to Zacks on Wednesday, 2 August, "While Upwork has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
• Upwork (upwk) reports Q2 earnings: what key metrics have to say. According to Zacks on Wednesday, 2 August, "For the quarter ended June 2023, Upwork (UPWK Quick QuoteUPWK – Free Report) reported revenue of $168.61 million, up 7.5% over the same period last year. ", "Here is how Upwork performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"

More news about Upwork.

Stay up to date with our premarket winners and losers daily report